Health Care

Valeant to Restate Results, Shares Fall

Valeant Pharmaceuticals said it would restate its financial results for 2014 and 2015 after identifying some sales to Philidor that should have been recognized when products were dispensed to patients.

IBM to Buy Data Company Truven Health Analytics for $2.6 Billion

International Business Machines Corp said it would buy Truven Health Analytics, a provider of cloud-based healthcare data, for $2.6 billion, the company's fourth major health-related acquisition since launching the Watson Health unit in April last year.

IBM to Acquire Truven Health Analytics for $2.6B

International Business Machines said on Thursday it plans to acquire Truven Health Analytics, a provider of healthcare data and analytics, for $2.6 billion, marking its fourth major health data-related deal in the past year.

Pfizer's 4Q Earnings Beat, Outlook Misses

Dow component Pfizer reported an adjusted 4Q profit of $0.53 per share, topping the estimate for $0.52. Revenue for the drugmaker came in at $14 billion, also beating the estimate for $13.56 billion.